Regeneus Ltd
ASX:RGS
Regeneus Ltd
ASX:RGS
Price:
0.009 AUD
Market Closed
Updated:
May 6, 2024
Regeneus Ltd
Operating Income
|
Regeneus Ltd
Operating Income Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Regeneus Ltd
ASX:RGS
|
Operating Income
-AU$2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
|
Immutep Ltd
ASX:IMM
|
Operating Income
-AU$46.9m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-13%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Operating Income
-$55.3m
|
CAGR 3-Years
21%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Operating Income
$3.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Operating Income
AU$50.8m
|
CAGR 3-Years
36%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Operating Income
AU$17.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Regeneus Ltd's Operating Income?
Operating Income
-2m
AUD
-2m
AUD
Based on the financial report for Dec 31, 2023, Regeneus Ltd's Operating Income amounts to -2m AUD.
What is Regeneus Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
12%
12%
Over the last year, the Operating Income growth was 54%.
You don't have any saved screeners yet
